在俄勒冈州和华盛顿州对低水平毒品持有合法化后,逮捕人数的变化
Corey S Davis1, Spruha Joshi2, Bianca D Rivera2
1Department of Population Health, Grossman School of Medicine, New York University Langone, 180 Madison Ave, 4th Floor New York, NY 10016, United States; Network for Public Health Law, 7101 York Avenue South, #270 Edina, MN 55435, United States.
The International journal on drug policy
|August 11, 2023
概括
俄勒冈州和华盛顿州的毒品非刑事化显著减少了持有毒品的逮捕,但没有增加暴力犯罪的逮捕. 这些政策变化显示出减少毒品使用者和社区的伤害的潜力.
科学领域:
- 公共卫生 公共卫生
- 犯罪学 犯罪学
- 药物政策 药物政策
背景情况:
- 美国的美国.
- 对毒品的战争 毒品的战争
- 与增加与药物有关的危害有关.
- 美国大多数州都将持有毒品定为犯罪.
- 俄勒冈州和华盛顿州在2021年部分或完全取消了毒品持有罪.
研究的目的:
- 评估俄勒冈州和华盛顿州毒品非犯罪化政策对逮捕率的影响.
- 为了比较这些州逮捕率的变化,以控制各州.
主要方法:
- 从2019-2021年获得的俄勒冈,华盛顿和控制州 (科罗拉多,爱达荷,蒙大拿,内华达) 的逮捕数据.
- 计算了各种犯罪类别的每月逮捕率.
- 利用中断时间序列分析来评估政策影响.
主要成果:
- 俄勒冈州和华盛顿州的毒品持有逮捕在政策实施后显著减少.
- 华盛顿也经历了毒品设备逮捕的减少.
- 与控制相比,干预国家没有观察到总体,非毒品或暴力犯罪逮捕的显著增加.
结论:
- 国家一级的毒品非刑事化可以大大减少持有毒品的逮捕.
- 这些政策可以在没有同时增加暴力犯罪的情况下实施.
- 需要对过量服用率和其他与药物相关的危害的影响进行进一步的研究.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
515
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
515
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact
184
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
184
Drug Dependence
1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Deindividuation
26.4K
Deindividuation is a form of social influence on an individual’s behavior such that the individual engages in unusual or non-normal behavior while in a group setting. Why? Because in these group settings, the individual no longer sees themselves as an individual anymore, disinhibiting their behavior and personal restraint.
26.4K


